David P. Kennedy is Director at 1Life Healthcare Inc (ONEM). They have made 16 open-market trades across 1 company since 2020, most recently 2023-03-08.
CIK 0001800529
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 16 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ONEM | SELL | 2021-09-20 | 2021-09-22 | $24.72 | $137K | -20.1% | -11.4% | -30.3% |
| ONEM | SELL | 2021-08-18 | 2021-08-20 | $23.40 | $130K | +8.0% | +8.8% | -11.0% |
| ONEM | SELL | 2021-07-19 | 2021-07-19 | $26.59 | $124K | +0.3% | -13.8% | -21.4% |
| ONEM | SELL | 2021-06-18 | 2021-06-22 | $33.60 | $373K | -4.0% | -20.9% | -29.4% |
| ONEM | SELL | 2021-06-02 | 2021-06-03 | $38.00 | $106K | -7.4% | -9.9% | -33.1% |
| ONEM | SELL | 2021-05-18 | 2021-05-20 | $33.62 | $290K | +8.6% | -0.2% | -33.4% |
| ONEM | SELL | 2021-04-19 | 2021-04-19 | $40.52 | $639K | +6.9% | -16.4% | -33.8% |
| ONEM | SELL | 2021-03-18 | 2021-03-19 | $40.07 | $465K | -2.2% | +2.5% | -15.4% |
| ONEM | SELL | 2021-02-18 | 2021-02-19 | $54.85 | $892K | -20.6% | -27.8% | -40.1% |
| ONEM | SELL | 2021-01-19 | 2021-01-20 | $46.33 | $441K | +5.4% | +10.8% | -19.2% |
| ONEM | SELL | 2020-12-18 | 2020-12-21 | $39.77 | $659K | +2.3% | +21.4% | -2.5% |
| ONEM | SELL | 2020-12-09 | 2020-12-11 | $38.03 | $317K | +12.7% | +7.9% | +13.3% |
| ONEM | SELL | 2020-11-18 | 2020-11-20 | $33.56 | $373K | +6.2% | +23.0% | +62.7% |
| ONEM | SELL | 2020-10-22 | 2020-10-26 | $32.00 | $89K | +1.7% | +5.7% | +67.3% |
| ONEM | SELL | 2020-10-19 | 2020-10-19 | $30.55 | $170K | -5.4% | +8.9% | +55.8% |
| ONEM | SELL | 2020-08-27 | 2020-08-31 | $29.10 | $2.9M | -5.5% | -2.8% | +12.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.